Daniel Chang, PHARMD, RPH
Pharmacist · Milpitas
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Daniel Chang’s office at (408) 942-9007 to ask if they take your plan before you enroll.
California Medical Board record
Licence G69731 · Cancelled
Licence status: Cancelled · since 1990 · University of Nebraska College of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$18,001
Pharmacies billed $18,001 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 84) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
0 generic and 84 brand-name prescriptions · $18,001 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Shingrix | 31 | $6,898 | $203 |
| Arexvy | 19 | $5,383 | $283 |
| Abrysvo | 16 | $4,684 | $293 |
| Boostrix Tdap | 13 | $831 | $64 |
Year by year
| 2024 | 84 | 69 | 0% (0) | 100% | $18,001 |
| 2023 | 125 | 108 | 0% (0) | 100% | $32,114 |
| 2022 | 32 | 29 | 0% (0) | 94% | $4,847 |
| 2021 | 33 | 29 | 0% (0) | 100% | $5,663 |
| 2020 | 57 | 45 | 0% (0) | 100% | $9,050 |
| 2019 | 37 | 27 | 0% (0) | 100% | $5,383 |
| 2018 | 11 | None | 0% (0) | 100% | $1,695 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Arexvy | 42 | $13,349 | $318 |
| Shingrix | 48 | $10,144 | $211 |
| Abrysvo | 23 | $7,673 | $334 |
| Boostrix Tdap | 11 | $763 | $69 |
2022: 1 drug
| Shingrix | 20 | $3,976 | $199 |
2021: 1 drug
| Shingrix | 28 | $5,267 | $188 |
2020: 1 drug
| Shingrix | 47 | $8,339 | $177 |
2019: 1 drug
| Shingrix | 28 | $4,709 | $168 |
Professional record
- NPI
- 1760869424
- Licence
- CA 69731California G69731: Cancelled
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 183500000X (183500000X)
- Mailing address
- Po Box 32974, San Jose, CA, 95152
- NPI first listed
- 2015-05-01
- NPI last updated
- 2015-05-01
This is when the NPI record was last certified, not a medical board exam.